Published in Am J Pathol on March 01, 1995
Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol (2005) 7.88
Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev (1996) 6.12
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol (1999) 6.03
Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol (2002) 4.87
A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev (2010) 4.64
Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol (2006) 4.00
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol (2000) 3.88
An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98. Emerg Infect Dis (2002) 3.36
Experimental infection model for Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus). Proc Natl Acad Sci U S A (2000) 2.55
beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci U S A (1998) 2.54
Monkeypox transmission and pathogenesis in prairie dogs. Emerg Infect Dis (2004) 2.45
Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol (2002) 2.36
Fatal encephalitis and myocarditis in young domestic geese (Anser anser domesticus) caused by West Nile virus. Emerg Infect Dis (2001) 2.03
Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol (1999) 2.03
Risk factors for severe Rift Valley fever infection in Kenya, 2007. Am J Trop Med Hyg (2010) 2.02
Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998. Emerg Infect Dis (2002) 1.89
Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol (2013) 1.75
Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A (2002) 1.74
The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol (2006) 1.66
Modern uses of electron microscopy for detection of viruses. Clin Microbiol Rev (2009) 1.63
Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever. J Virol (2006) 1.56
Hantavirus transmission in the United States. Emerg Infect Dis (1997) 1.55
Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol (2001) 1.50
Hantavirus pulmonary syndrome, United States, 1993-2009. Emerg Infect Dis (2011) 1.48
Discernment between deliberate and natural infectious disease outbreaks. Epidemiol Infect (2006) 1.44
Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses. Biomed Res Int (2015) 1.43
Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J Virol (2010) 1.40
Complete genetic characterization and analysis of isolation of Sin Nombre virus. J Virol (1995) 1.38
Immunological mechanisms mediating hantavirus persistence in rodent reservoirs. PLoS Pathog (2008) 1.37
The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med (2010) 1.36
Role of actin microfilaments in Black Creek Canal virus morphogenesis. J Virol (1998) 1.34
Long-lived memory T lymphocyte responses after hantavirus infection. J Exp Med (2002) 1.34
Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol (2007) 1.32
Transmission study of Andes hantavirus infection in wild sigmodontine rodents. J Virol (2004) 1.31
Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters. J Virol (2007) 1.30
Pathogenic hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent alphavbeta3 integrin conformers. Proc Natl Acad Sci U S A (2005) 1.29
Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence. J Virol (2000) 1.29
Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc Natl Acad Sci U S A (2007) 1.28
The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. J Virol (2008) 1.24
Treatment of hantavirus pulmonary syndrome. Antiviral Res (2007) 1.21
Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers? Immunol Lett (2007) 1.21
Induction of innate immune response genes by Sin Nombre hantavirus does not require viral replication. J Virol (2005) 1.20
Temporal and spatial analysis of Sin Nombre virus quasispecies in naturally infected rodents. J Virol (1999) 1.18
Hantavirus infection of dendritic cells. J Virol (2002) 1.18
Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. J Virol (2003) 1.17
Polarized entry and release in epithelial cells of Black Creek Canal virus, a New World hantavirus. J Virol (1997) 1.17
Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus. PLoS Pathog (2011) 1.17
Outbreak of hantavirus pulmonary syndrome, Los Santos, Panama, 1999-2000. Emerg Infect Dis (2004) 1.17
The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. Am J Pathol (2003) 1.17
Sin Nombre virus pathogenesis in Peromyscus maniculatus. J Virol (1999) 1.16
Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J Virol (2004) 1.16
Hantavirus-induced disruption of the endothelial barrier: neutrophils are on the payroll. Front Microbiol (2015) 1.13
Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur J Clin Microbiol Infect Dis (2011) 1.12
Effects of tumor necrosis factor alpha on sin nombre virus infection in vitro. J Virol (2000) 1.12
T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome. J Virol (2011) 1.10
The Syrian hamster model of hantavirus pulmonary syndrome. Antiviral Res (2012) 1.10
Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006-2007. Am J Trop Med Hyg (2010) 1.09
Hantavirus pulmonary syndrome in a Chilean patient with recent travel in Bolivia. Emerg Infect Dis (1998) 1.09
Loss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J Virol (2006) 1.09
Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. J Virol (2010) 1.08
T cells cause acute immunopathology and are required for long-term survival in mouse adenovirus type 1-induced encephalomyelitis. J Virol (2003) 1.07
Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. J Virol (2010) 1.06
Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55). J Virol (2008) 1.05
Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein. J Virol (1999) 1.05
Pathology and immunohistochemistry of callitrichid hepatitis, an emerging disease of captive New World primates caused by lymphocytic choriomeningitis virus. Am J Pathol (1995) 1.03
Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail. J Virol (2003) 1.02
VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability. J Virol (2010) 1.02
Hantaviruses in the americas and their role as emerging pathogens. Viruses (2010) 1.02
Elevated VEGF Levels in Pulmonary Edema Fluid and PBMCs from Patients with Acute Hantavirus Pulmonary Syndrome. Adv Virol (2012) 0.99
Venezuelan equine encephalitis virus infection of spiny rats. Emerg Infect Dis (2005) 0.98
New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells. PLoS One (2010) 0.98
Bidirectional virus secretion and nonciliated cell tropism following Andes virus infection of primary airway epithelial cell cultures. J Virol (2006) 0.98
Andes virus regulation of cellular microRNAs contributes to hantavirus-induced endothelial cell permeability. J Virol (2010) 0.98
Kinetics of immune responses in deer mice experimentally infected with Sin Nombre virus. J Virol (2012) 0.98
Sustained high level of serum VEGF at convalescent stage contributes to the renal recovery after HTNV infection in patients with hemorrhagic fever with renal syndrome. Clin Dev Immunol (2012) 0.97
Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness. PLoS One (2011) 0.96
Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor. J Virol (2005) 0.96
Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J Virol (2011) 0.96
Hantavirus infections among overnight visitors to Yosemite National Park, California, USA, 2012. Emerg Infect Dis (2014) 0.96
Choclo virus infection in the Syrian golden hamster. Am J Trop Med Hyg (2008) 0.95
Cloning and characterization of deer mouse (Peromyscus maniculatus) cytokine and chemokine cDNAs. BMC Immunol (2004) 0.95
Pathology of Puumala hantavirus infection in macaques. PLoS One (2008) 0.95
Controversies in dengue pathogenesis. Paediatr Int Child Health (2012) 0.95
Degrons at the C terminus of the pathogenic but not the nonpathogenic hantavirus G1 tail direct proteasomal degradation. J Virol (2007) 0.95
Experimental Andes virus infection in deer mice: characteristics of infection and clearance in a heterologous rodent host. PLoS One (2013) 0.94
T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome. Viruses (2011) 0.94
New York 1 and Sin Nombre viruses are serotypically distinct viruses associated with hantavirus pulmonary syndrome. J Clin Microbiol (1999) 0.93
Potential renal sequelae in survivors of hantavirus cardiopulmonary syndrome. Am J Trop Med Hyg (2009) 0.93
Clusters of hantavirus infection, southern Argentina. Emerg Infect Dis (2007) 0.93
Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice. J Virol (2002) 0.92
Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. PLoS Pathog (2013) 0.92
High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. Clin Infect Dis (2013) 0.92
Andes virus recognition of human and Syrian hamster beta3 integrins is determined by an L33P substitution in the PSI domain. J Virol (2010) 0.92
Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis. PLoS Pathog (2013) 0.91
Diagnosis of influenza from respiratory autopsy tissues: detection of virus by real-time reverse transcription-PCR in 222 cases. J Mol Diagn (2011) 0.91
The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster. Immunology (2013) 0.91
The C-terminal 42 residues of the Tula virus Gn protein regulate interferon induction. J Virol (2011) 0.90
Bench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentation. Crit Care (2008) 0.90
Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerg Infect Dis (1999) 0.90
Germinal centers. Annu Rev Immunol (1994) 10.85
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61
Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis (1994) 4.97
Pulmonary lesions associated with oxygen therapy and artifical ventilation. N Engl J Med (1967) 3.87
Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am J Pathol (1988) 3.72
Cytokine regulation of endothelial cell function. FASEB J (1992) 3.00
HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol (1986) 2.77
Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am J Pathol (1989) 2.72
Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res (1993) 2.57
Phylogenetic analyses of virus isolates in the genus Hantavirus, family Bunyaviridae. Virology (1994) 2.47
Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. Am J Pathol (1992) 2.37
Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy. Am J Pathol (1989) 2.33
Serological relationships among viruses in the Hantavirus genus, family Bunyaviridae. Virology (1994) 2.20
Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg (1994) 2.07
Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology (1994) 2.01
Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol (1995) 2.00
Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology (1983) 1.83
A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses. J Virol (1994) 1.78
Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med (1994) 1.68
Hantaan virus infection of human endothelial cells. J Virol (1992) 1.65
Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis (1991) 1.60
Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch Virol (1990) 1.49
Expression of RNA and antigens of human immunodeficiency virus type-1 (HIV-1) in lymph nodes from HIV-1 infected individuals. Am J Pathol (1988) 1.48
Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. Am J Pathol (1994) 1.39
Lymphocyte recruitment to the lung. Am Rev Respir Dis (1990) 1.37
Genetic identification of a novel hantavirus of the harvest mouse Reithrodontomys megalotis. J Virol (1994) 1.34
Hantavirus pulmonary syndrome: an emerging infectious disease. Science (1993) 1.28
Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala. Arch Virol (1991) 1.26
Early lymphoreticular viral tropism and antigen persistence. Tamiami virus infection in the cotton rat. Lab Invest (1976) 1.24
HIV-1 infection and virus production in follicular dendritic cells in lymph nodes. A case report, with analysis of isolated follicular dendritic cells. Am J Pathol (1990) 1.24
Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. Lab Invest (1991) 1.24
Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection (1992) 1.21
Organ-derived microvessel endothelial cells exhibit differential responsiveness to thrombin and other growth factors. Microvasc Res (1992) 1.18
Epidemiology of Hantaan and related viruses. Lab Anim Sci (1987) 1.17
The pathology of thirty-nine fatal cases of epidemic hemorrhagic fever. Am J Med (1954) 1.13
The central role of follicular dendritic cells in lymphoid tissues. Adv Immunol (1992) 1.13
Adhesion molecules in the lung. An overview. Am Rev Respir Dis (1993) 1.13
Hemorrhagic fever: a study of 300 cases. Medicine (Baltimore) (1954) 1.10
Effects of interferon-gamma on primary cultures of human brain microvessel endothelial cells. Am J Pathol (1993) 1.09
Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells. Am J Pathol (1994) 1.07
Abnormalities of T cell immunoregulation in hemorrhagic fever with renal syndrome. J Infect Dis (1990) 1.03
A retrospective analysis of sera collected by the Hemorrhagic Fever Commission during the Korean Conflict. J Infect Dis (1990) 1.03
Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever). Rev Infect Dis (1989) 1.03
Immunofluorescence studies of disseminated Hantaan virus infection of suckling mice. Infect Immun (1983) 1.02
Nucleotide sequence of the L genome segment of Hantaan virus. Nucleic Acids Res (1990) 1.02
Clinical features of HFRS in Scandinavia as compared with East Asia. Scand J Infect Dis Suppl (1982) 0.99
Pulmonary pathology in acute respiratory insufficiency: lung biopsy as a diagnostic tool. J Thorac Cardiovasc Surg (1976) 0.99
Retrospective diagnosis of a 1983 case of fatal hantavirus pulmonary syndrome. Lancet (1994) 0.95
Hantavirus pulmonary syndrome. Am J Respir Crit Care Med (1994) 0.94
Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever H. Am J Clin Pathol (1993) 0.94
Etiology and epidemiology of the Four Corners hantavirus outbreak. Infect Agents Dis (1994) 0.91
Pathology of hemorrhagic fever: a comparison of the findings; 1951 and 1952. Am J Pathol (1955) 0.91
Studies on immunopathogenesis in epidemic hemorrhagic fever: sequential observations on activation of the first complement component in sera from patients with epidemic hemorrhagic fever. J Immunol (1981) 0.88
The minor problem of hemostatic impairment in nephropathia epidemica, the mild Scandinavian form of hemorrhagic fever with renal syndrome. Rev Infect Dis (1989) 0.86
Morphology and morphogenesis of viruses of hemorrhagic fever with renal syndrome. II. Inclusion bodies--ultrastructural markers of hantavirus-infected cells. Intervirology (1987) 0.86
The role of tissue immune complex, complement activation and its immunopathologic injury in the pathogenesis of the epidemic hemorrhagic fever. Chin Med J (Engl) (1986) 0.85
Distribution pattern of follicular dendritic cells in low grade B-cell lymphomas of the gastrointestinal tract immunostained by Ki-FDC1p: a new paraffin-resistant monoclonal antibody. Mod Pathol (1990) 0.85
Hemodynamic alterations in hemorrhagic fever. Circulation (1957) 0.84
Identification of Hantaan virus-related structures in kidneys of cadavers with haemorrhagic fever with renal syndrome. Arch Virol (1992) 0.84
Morphology and morphogenesis of viruses of hemorrhagic fever with renal syndrome (HFRS). I. Some peculiar aspects of the morphogenesis of various strains of HFRS virus. Intervirology (1985) 0.83
Localization and changes of hemorrhagic fever with renal syndrome virus in lymphocyte subpopulation. Chin Med J (Engl) (1991) 0.82
Clinical aspects of the renal phase of epidemic hemorrhagic fever. Ann Intern Med (1953) 0.82
Effects of Hantaan virus on human endothelial cells and their significance in pathogenesis of hemorrhagic fever with renal syndrome. Chin Med J (Engl) (1991) 0.82
CLINICAL ANALYSIS OF 111 FATAL CASES OF EPIDEMIC HEMORRHAGIC FEVER. Am J Med (1965) 0.82
Endotoxin enhancement of lymphocyte adherence to cultured sheep lung microvascular endothelial cells. Am J Respir Cell Mol Biol (1992) 0.81
Activation of the alternative complement pathway in patients with epidemic hemorrhagic fever. Chin Med J (Engl) (1984) 0.80
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72
Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol (1991) 6.00
Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96
The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med (1994) 4.66
Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28
THE MOUSE INFECTIVITY TITRATION OF INFLUENZA VIRUS. J Exp Med (1944) 3.53
Identification of a human population infected with simian foamy viruses. Nat Med (1998) 3.47
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis (2001) 3.42
Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36
Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis (1999) 3.34
Reye's syndrome in the United States from 1981 through 1997. N Engl J Med (1999) 3.20
SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell (1995) 2.96
Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein. Proc Natl Acad Sci U S A (1977) 2.93
Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg (1997) 2.66
A plasmid-encoded regulatory gene, rns, required for expression of the CS1 and CS2 adhesins of enterotoxigenic Escherichia coli. Proc Natl Acad Sci U S A (1989) 2.62
Experimental infection model for Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus). Proc Natl Acad Sci U S A (2000) 2.55
A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology (2001) 2.28
Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis (1999) 2.27
Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med (1995) 2.27
Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg (1995) 2.26
Feline leukemia virus: biochemical and immunological characterization of gag gene-coded structural proteins. J Virol (1977) 2.26
Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci U S A (1981) 2.26
Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis (1999) 2.22
Nucleotide sequence analysis establishes the role of endogenous murine leukemia virus DNA segments in formation of recombinant mink cell focus-forming murine leukemia viruses. J Virol (1984) 2.15
Endogenous murine leukemia proviral long terminal repeats contain a unique 190-base-pair insert. Proc Natl Acad Sci U S A (1983) 2.10
Cloning and characterization of an envelope-specific probe from xenotropic murine leukemia proviral DNA. J Virol (1982) 2.09
Specific hybridization probes demonstrate fewer xenotropic than mink cell focus-forming murine leukemia virus env-related sequences in DNAs from inbred laboratory mice. J Virol (1986) 2.08
Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg (1994) 2.07
Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis (1999) 2.05
Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis (1999) 2.04
High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis (1999) 2.02
Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol (1995) 2.00
A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 1.96
Double recombination of a single immunoglobulin kappa-chain allele: implications for the mechanism of rearrangement. Proc Natl Acad Sci U S A (1985) 1.95
Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J Clin Microbiol (1997) 1.91
Negative control region at the 5' end of murine leukemia virus long terminal repeats. Mol Cell Biol (1989) 1.88
Ready or not--preparedness for bioterrorism. N Engl J Med (2001) 1.88
Pathogenic potential of filoviruses: role of geographic origin of primate host and virus strain. J Infect Dis (1992) 1.84
Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol (1999) 1.83
The incubation period of hantavirus pulmonary syndrome. Am J Trop Med Hyg (2000) 1.81
The natural history of untreated asymptomatic hips in patients who have non-traumatic osteonecrosis. J Bone Joint Surg Am (1997) 1.80
Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience. Crit Care Med (1992) 1.75
An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg (1997) 1.68
Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi. J Urol (1998) 1.67
Recombinant human monoclonal antibodies to Ebola virus. J Infect Dis (1999) 1.65
Characterization of proviruses cloned from mink cell focus-forming virus-infected cellular DNA. J Virol (1982) 1.60
Consensus conference on second opinions in diagnostic anatomic pathology. Who, What, and When. Am J Clin Pathol (2000) 1.60
Antibiotic treatment of parturient women colonized with group B streptococci. Am J Obstet Gynecol (1976) 1.60
Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med (1997) 1.60
High-grade non-Hodgkin lymphoma relapsing as low-grade follicular lymphoma: so-called downgraded lymphoma. Am J Hematol (1989) 1.57
Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis. Am J Ophthalmol (2000) 1.57
Use of 3' untranslated sequences of human cDNAs for rapid chromosome assignment and conversion to STSs: implications for an expression map of the genome. Nucleic Acids Res (1991) 1.55
Hantavirus transmission in the United States. Emerg Infect Dis (1997) 1.55
Anaplastic myeloma with massive extramedullary involvement. Report of two cases. Cancer (1983) 1.54
An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis (1999) 1.54
Lethal intrauterine fetal trauma. Am J Obstet Gynecol (1988) 1.53
Sinonasal papillomas and human papillomavirus: human papillomavirus 11 detected in fungiform Schneiderian papillomas by in situ hybridization and the polymerase chain reaction. Hum Pathol (1991) 1.51
Evidence against person-to-person transmission of hantavirus to health care workers. Clin Infect Dis (1996) 1.50
Dermal lymphangiomata of the vulva and laser therapy: a case report and literature review. Eur J Gynaecol Oncol (1999) 1.49
Novel type of fimbriae encoded by the large plasmid of sorbitol-fermenting enterohemorrhagic Escherichia coli O157:H(-). Infect Immun (2001) 1.48
Re-emergence of human monkeypox in Zaire in 1996. Monkeypox Epidemiologic Working Group. Lancet (1997) 1.45
Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. J Infect Dis (1995) 1.45
Incorrect death certification. An invitation to obfuscation. Postgrad Med (1987) 1.42
Hematogones: a multiparameter analysis of bone marrow precursor cells. Blood (1989) 1.42
Thallium imaging for brain tumors with results measured by a semiquantitative index and correlated with histopathology. Cancer (1994) 1.42
Filovirus diseases. Curr Top Microbiol Immunol (1999) 1.42
Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma. Mod Pathol (2000) 1.42
Effect of high altitude on neutrophil counts in newborn infants. J Pediatr (1991) 1.41
Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. Am J Clin Pathol (2000) 1.41
Reemergence of Ebola virus in Africa. Emerg Infect Dis (1996) 1.40
Two separate unintentional fatalities with the same revolver. Ann Emerg Med (2001) 1.39
Occult glove perforations: frequency during interventional radiologic procedures. AJR Am J Roentgenol (1992) 1.39
Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood (1994) 1.38
Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol (1999) 1.37
Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Ther (2010) 1.35
Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol (1981) 1.34
Nucleotide sequence of the env-specific segment of NFS-Th-1 xenotropic murine leukemia virus. J Virol (1983) 1.34
Studies on human immunodeficiency virus-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells. Arch Virol (1988) 1.33
Cytomegalovirus mononucleosis in a first trimester pregnant female with transmission to the fetus. Pediatrics (1971) 1.31
Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group. Antivir Ther (1999) 1.31
Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric-restricted animals. J Gerontol A Biol Sci Med Sci (1999) 1.29
Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 1.29
Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis (1999) 1.29
Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J Neurochem (2005) 1.26
Growth properties of human herpesvirus-6 strain Z29. J Virol Methods (1989) 1.23
Corpus gastritis is protective against reflux oesophagitis. Gut (1999) 1.23
Epidemiology of Creutzfeldt-Jakob disease in the United States, 1979-1990: analysis of national mortality data. Neuroepidemiology (1995) 1.22
Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs. Am J Clin Pathol (2000) 1.22
Life-threatening Cache Valley virus infection. N Engl J Med (1997) 1.19
Two cases of endocardial fibroelastosis--possible x-linked determination. Br Heart J (1973) 1.19
Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol (1995) 1.19
Lack of evidence for infection with known human and animal retroviruses in patients with chronic fatigue syndrome. Clin Infect Dis (1994) 1.17